CytomX Therapeutics Inc (NASDAQ: CTMX) kicked off on Monday, down -4.56% from the previous trading day, before settling in for the closing price of $4.39. Over the past 52 weeks, CTMX has traded in a range of $0.40-$4.62.
While this was happening, its average annual earnings per share was recorded -108.84%. With a float of $127.86 million, this company’s outstanding shares have now reached $165.07 million.
CytomX Therapeutics Inc (CTMX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of CytomX Therapeutics Inc is 24.54%, while institutional ownership is 65.29%. The most recent insider transaction that took place on Nov 06 ’25, was worth 461,906. In this transaction CEO of this company sold 101,793 shares at a rate of $4.54, taking the stock ownership to the 987,891 shares. Before that another transaction happened on Nov 06 ’25, when Company’s CEO proposed sale 101,793 for $4.54, making the entire transaction worth $461,909.
CytomX Therapeutics Inc (CTMX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.23 earnings per share (EPS), higher than consensus estimate (set at -0.11) by 0.34. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -108.84% per share during the next fiscal year.
CytomX Therapeutics Inc (NASDAQ: CTMX) Trading Performance Indicators
Take a look at CytomX Therapeutics Inc’s (CTMX) current performance indicators. Last quarter, stock had a quick ratio of 3.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.42, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of CytomX Therapeutics Inc (CTMX)
Analysing the last 5-days average volume posted by the [CytomX Therapeutics Inc, CTMX], we can find that recorded value of 1.84 million was lower than the volume posted last year of 3.32 million. As of the previous 9 days, the stock’s Stochastic %D was 76.68%.
During the past 100 days, CytomX Therapeutics Inc’s (CTMX) raw stochastic average was set at 85.17%, which indicates a significant increase from 58.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.26 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.89, while its 200-day Moving Average is $2.43. Now, the first resistance to watch is $4.33. This is followed by the second major resistance level at $4.48. The third major resistance level sits at $4.55. If the price goes on to break the first support level at $4.11, it is likely to go to the next support level at $4.04. Now, if the price goes above the second support level, the third support stands at $3.89.
CytomX Therapeutics Inc (NASDAQ: CTMX) Key Stats
The company with the Market Capitalisation of 709.93 million has total of 169,435K Shares Outstanding. Its annual sales at the moment are 138,100 K in contrast with the sum of 31,870 K annual income. Company’s last quarter sales were recorded 5,960 K and last quarter income was -14,230 K.
